Tocilizumab preserves lung function in systemic sclerosis
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=AWG4Nnk05Rc
Tocilizumab (Actemra) preserved lung function in patients with early systemic sclerosis (SSc), according to a secondary endpoint analysis of the phase 3, double-blind, randomized, controlled focuSSced trial. • • Read more: https://www.mdedge.com/rheumatology/a...
#############################
